Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Updates Guidance On Labeling Passive Implants For MRI

This article was originally published in The Gray Sheet

Executive Summary

The agency has revised a 2008 guidance to spell out when it is OK to state in labeling that a non-electronic, or passive, implant has not been evaluated for safe use in a magnetic resonance environment, among other clarifications.


Related Content

Podcast: FDA, Med Institute Studying MRI Safety of Passive Devices
FDA Should Use “Bully Pulpit” To Lower MRI Accident Rate, Workshop Goers Say
MRI Safety Guidance Outlines Testing, Labeling Terms For Passive Implants



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts